2015
DOI: 10.1016/j.cca.2015.09.028
|View full text |Cite
|
Sign up to set email alerts
|

An efficient and robust fatty acid profiling method for plasma metabolomic studies by gas chromatography–mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
6
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 35 publications
2
6
2
Order By: Relevance
“…The intra‐ and inter‐day accuracies (Table ) were assessed by the ratio of the measured concentration versus a known, spiked concentration, and these values were 90.51–109.59 and 94.57–109.33%, respectively. The precision and reproducibility were comparable with recent work using GC–MS .…”
Section: Resultssupporting
confidence: 85%
See 3 more Smart Citations
“…The intra‐ and inter‐day accuracies (Table ) were assessed by the ratio of the measured concentration versus a known, spiked concentration, and these values were 90.51–109.59 and 94.57–109.33%, respectively. The precision and reproducibility were comparable with recent work using GC–MS .…”
Section: Resultssupporting
confidence: 85%
“…spiked concentration, and these values were 90.51-109.59 and 94.57-109.33%, respectively. The precision and reproducibility were comparable with recent work using GC-MS [14,20].…”
Section: Performance Of Gc-ms Methodssupporting
confidence: 84%
See 2 more Smart Citations
“…Likewise, Jobard et al [ 134 ] identified a set of nine metabolites (histidine, acetoacetate, glycerol, pyruvate, N-acetyl glycoproteins (NAC 1 and 2), mannose, glutamate, and phenylalanine) associated with advanced metastatic disease. Three fatty acids (C22:0, C24:0, and C18:2n6 - namely behenic acid, lignoceric acid, and linoleic acid, respectively) were identified to be significantly reduced in plasma of premenopausal and postmenopausal breast cancer patients [ 135 ]. Yet another study suggested mainly two markers, lysophosphatidylethanolamine and ceramide, to play an important role in invasive ductal carcinoma [ 136 ].…”
Section: Blood-based Metabolome Analyses and Biomarkersmentioning
confidence: 99%